Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.
Auris Nasus Larynx
; 50(4): 521-533, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-36599786
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Otitis Media
/
Otitis Media, Suppurative
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Auris Nasus Larynx
Year:
2023
Document type:
Article
Affiliation country:
Japón